Conference Overview

The 4th Annual Global Clinical Trials Connect 2021 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.

 

The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.

 

This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.

This program will certainly educate health care scientists on trial design, operations, organizing trials, research computing, regulatory aspects, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention, diagnosis, clinical trial-related ethics and disease treatments.

 

"The Virtual summit will facilitate an invaluable networking opportunities with Decision makers and Industry experts, focusing on real case studies and insightful presentations.Bringing in Exciting features like Q&A Sessions with industry experts, Networking Video Chat, Polling, Raise Hand, Virtual Exhibitor booths with waiting room/tables and virtual chat, Peer to Peer connect at Social Lounge, Handout Bags and more giving opportunity to grow and expand your networking throughout the event"

 

It gives us a great pleasure in welcoming you to our whole new Virtual conference 4th Annual Global Clinical Trials Connect 2021.

 


KEY HIGHLIGHTS

  • Patient Recruitment and Site selection
  • Innovative trial designs
  • Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
  • Patient centric clinical trials
  • Making Patient Engagement a Reality
  • New innovations in Patient Recruitment planning and execution on a clinical trial
  • Outsourcing strategies and models
  • Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
  • Streamlined IRT development process
  • Pharmacovigilance & Clinical Trials
  • Post-Clinical Trial closed communities
  • How to future proof your clinical operations
  • Implementing Risk Based Monitoring
  • Streamlining R&D and lower costs in clinical trials
  • Adaptive Trial Model
  • Clinical Trial Auditing
  • Real World Clinical Trial Strategies
  • Data Quality & Technology
  • Clinical Data Strategy & Analytics
  • Electronic Data Capture (EDC) Systems
  • Clinical Technology and Driving Innovation
  • M-Health, Wearable and Consumer Technology
  • Big-Data, IoT and Artificial Intelligence in Clinical trials
  • Blockchain technology for improving clinical research quality

 


WHO SHOULD ATTEND THE CONFERENCE

 

This event is designed for senior level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution provider and Government institutions.

 

Attendees includes VPs, GMs, Directors, Heads and Managers of

  • Clinical Trials
  • Clinical Study Management
  • Clinical Operations
  • Clinical Research
  • Patient Organizations
  • Patient Recruitment
  • Outsourcing
  • Vendor Management
  • Site Management
  • Site Monitoring
  • Clinical Pharmacology
  • IT
  • Clinical Data Management
  • EDC
  • Clinical/Digital Innovation
  • Clinical Design/Protocol design/ Strategy makers
  • Clinical Research Sites
  • CROs and CMOs
  • Hospitals/ Associations
  • Regulatory affairs 

Speakers

VIEW ALL

There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to [email protected]



Wednesday - 5th May 2021 (TimeZone BST)

  • 10:00
  • Welcome Address & Platform Orientation - Orientation will focus on how to access and navigate the virtual conference platform for Live Sessions & Interactive Networking

  • 10:25
  • Chairperson's opening remarks


    Nancy Meyerson-Hess

    Nancy Meyerson-HessChief Compliance and Regulatory Officer
    eMQT

  • 10:30
  • Enrolment and retention in clinical studies before and during Covid-19 pandemic: clinical challenges and new opportunities. A case report from a phase 3 clinical program in fibromyalgia


    Domenico Merante

    Domenico MeranteGlobal Clinical Development Therapeutic Area Clinical Lead Nephrology and Orphan Diseases
    Vifor pharma

  • 11:00
  • Case Study: DEEP (Digital Endpoints Ecosystem & Protocols)

    • DEEP is an accelerator offering a marketplace and a thriving ecosystem of services to accelerate the adoption of digital measures
    • DEEP enables access to assets between multiple parties, based on collaboration, transparency and trust
    • DEEP provides consistency in harmonious execution and more efficient application of digital measures, using aligned standards

    Erwin De Beuckelaer

    Erwin De BeuckelaerDirector Innovative Capabilities
    Janssen Pharmaceutical

  • 11:30
  • Health Equity and the importance of Advancing Inclusive Research


    Esther Middleditch

    Esther MiddleditchProject Lead, Health Equity & Population Science, PDMA
    F. Hoffmann-La Roche Ltd

  • 12:00
  • Taking the guesswork out of patient referrals


    Andy Cosgrove

    Andy CosgroveChief Commercial Officer
    Saphetor Life Sciences

  • 12:30
  • Virtual Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge (Face to Face Video Chats)

Patient Recruitment & Site Selection

  • 13:10
  • Efficient Patient Recruitment and targeted approach for Diabetes Trials


    Asude Ademogullari

    Asude AdemogullariClinical Development Center Head
    Novo Nordisk

  • 13:40
  • Advances in Predictive Analytic Modelling of Clinical Trails Operations

    • Predictive modelling to maximize recruitment predictability
    • Optimal operational design, sites/countries selection
    • Risk-based monitoring and forecasting trial performance
    • Forecasting event counts in event-driven trials

    Vladimir Anisimov

    Vladimir AnisimovPrincipal Data Scientist | Data Science | Center for Design & Analysis
    Amgen

  • 14:10
  • The National Institute for Health Research (NIHR) Patient Recruitment Centres: Optimising patient recruitment to ensure trial success


    Richard Evans

    Richard EvansNational Patient Recruitment Centre Manager
    NIHR (National Institute for Health Research)

  • 14:40
  • Site Landscape: Benchmark your site to address the Challenges Associated With Site Selection For Clinical Trials


    Jimmy Bechtel

    Jimmy BechtelVice President, Site Engagement
    SCRS

  • 15:10
  • Visit Virtual Exhibitor Booths/Speed Networking at our Exclusive Lounge (Face to Face Video chat with Exhibitors and other attendees)

  • 15:30
  • Panel discussion: Novel approaches to streamline site selection and reduce delay in recruitment to ensure success

    • Discover sites with a demonstrated track record of good execution in trials
    • Study and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.
    • Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be considered
    • Access to subject population with the required eligibility criteria
    • Network within industries

    Nancy Meyerson-Hess

    Nancy Meyerson-HessChief Compliance and Regulatory Officer
    eMQT

    Sebastian Stratmann

    Sebastian StratmannSenior Manager Clinical Innovation Biopharma R&D
    Healthcare Business of Merck

    Jimmy Bechtel

    Jimmy BechtelVice President, Site Engagement
    SCRS

Patient Centricity & Patient Engagement

  • 16:00
  • Case study: Embedding a patient-centric approach to clinical trial design

    • Examine learning points from multiple studies engaging patients at the protocol design stage
    • Understand the importance of the independent intermediary
    • Analyse the outcomes - evidencing the impact of earlier involvement

    Gareth Powell

    Gareth PowellBusiness Development Officer
    NIHR

  • 16:30
  • EU-PEARL: An EU patient-centric clinical trial platform


    Nadir Ammour

    Nadir AmmourGlobal Lead, Clinical Innovation & External Partnership
    Sanofi

  • 17:00
  • Chairperson’s closing remarks


    Nancy Meyerson-Hess

    Nancy Meyerson-HessChief Compliance and Regulatory Officer
    eMQT

  • 17:10
  • Networking - Catch-up with your peers in social lounge


Thursday - 6th May 2021 (TimeZone BST)

  • 10:00
  • Day 2 Welcome Address

  • 10:25
  • Chairperson's opening remarks


    Nancy Meyerson-Hess

    Nancy Meyerson-HessChief Compliance and Regulatory Officer
    eMQT

  • 10:30
  • eTMF as an active study Management tool, as well as a study health measure for inspection readiness and CRO performance


    Noeleen Valenzuela

    Noeleen ValenzuelaAssociate Director, Trial Master File and Document Management System
    Alnylam Pharmaceuticals

Outsourcing and Partnerships in Clinical Trials

  • 11:00
  • Patient partnering strategies in clinical research

    • All partnerships partnerships require honesty and mutual ROI
    • Patient ROI: The burden of therapy and burden of trial participation from the patient’s perspective
    • Pharma ROI: The impact of covid on moving pharma towards hybrid trials
    • Society ROI: The future of patient-driven trials and the impact of patient preferences on access and approval
    • The triple-win from effective patient partnering strategies in clinical research

    Emma Sutcliffe

    Emma SutcliffeSVP, Patient Insights and Solutions
    Prime Global

  • 11:30
  • Making patient advocacy a reality starting involving patients at Early stages


    Theodora V

    Theodora VPatient Centric Drug Development - Patient Advocacy and Public Affairs Lead EMEA/APAC
    Ionis Pharmaceuticals

  • 12:00
  • Setting up Your Decentralised Trial for Success


    Angel Soubhie

    Angel SoubhieHead clinical trial scientists - Medical Director
    Bayer

  • 12:30
  • Virtual Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge (Face to Face Video Chats)

  • 13:10
  • Establishing quality partnerships between sponsor and CROs

    • Having a shared vision in sponsor–vendor relationships
    • Involving the CRO in the project design and planning
    • Decide on the Quality Agreement and CRO Oversight Plan upfront

    Tamzin Blagbrough

    Tamzin BlagbroughSourcing consultant
    Eli Lilly

  • 13:40
  • Exclusive Case Study: The role of surrogate markers in (cardiovascular) drug development

    The session will highlight the importance of surrogate markers in general for drug development and in the field of cardiovascular research in particular. Following aspects will be covered in the presentation:


    • Inform / de-risk phase III
    • Proof of Concept
    • Enrich patient population
    • Label enhancement

    Marc Ditmarsch

    Marc DitmarschVP Clinical & Operations
    NewAmsterdam Pharma

  • 14:10
  • True Global Diversity in our Trials: Africa is Ready


    Shalom Lloyd

    Shalom LloydCo-Founder & Chief Strategy Officer
    eMQT

    Tina Barton

    Tina BartonChief Operating Officer
    eMQT

Quality, Compliance and Risk Management

  • 14:40
  • The Regulatory path to Quality by Design - ICH E8 R1 and ICH E6 R3


    Andy Lawton

    Andy LawtonConsultant
    Risk Based Approach Ltd

  • 15:10
  • Patient engagement in clinical trials: Necessities and benefits and for whom?


    Mary Lynne Van Poelgeest-Pomfret

    Mary Lynne Van Poelgeest-PomfretInternational patient advocate
    World Federation for Incontinent Patients - WFIP

  • 15:40
  • Visit Virtual Exhibitor Booths/Speed Networking at our Exclusive Lounge (Face to Face Video chat with Exhibtors and other attendees)

Clinical Data and Tech Driven Trials

  • 16:00
  • Blockchain is not only for Crypto. Pharmaledger’s journey through its clinical trial Use Cases: eRecruitement and eConsent


    Despina Daliani

    Despina DalianiClinical Trial eConsent & eRecruitment Use Cases Co-Lead
    Onorach/PharmaLedger

  • 16:30
  • Leverage AI to create value in Clinical Trials


    Bhupathy Alagiriswamy

    Bhupathy AlagiriswamyClinical Trial Manager
    Boehringer Ingelheim

  • 17:00
  • Clinical trials in the era of digitization - the impact of smart innovations in clinical research

    • Rethinking the R&D Clinical Process
    • Patient-Centred Innovation in Clinical Trials
    • New trial designs and analysis methods
    • Discovering and validating sequential,personalized decision-making strategies
    • An Integrated Business Model – Using technology to streamline processes

    Maria Palombini

    Maria PalombiniLeader, Healthcare Life Sciences Practice
    IEEE Standards Association

  • 17:30
  • Panel Discussion - A collaborative clinical ecosystem: How to effectively manage partnerships with all Stakeholders including Patients, Sites,CROs, Sponsors and Regulators.

    • Managing continuous & real-time collaboration
    • How transparency will lead to industrywide collaboration
    • Both sponsor and CRO must invest time in defining goals, anticipating issues and measuring results.
    • Considering what patient centricity factors your CRO brings in

    Nancy Meyerson-Hess

    Nancy Meyerson-HessChief Compliance and Regulatory Officer
    eMQT

    Mary Lynne Van Poelgeest-Pomfret

    Mary Lynne Van Poelgeest-PomfretInternational patient advocate
    World Federation for Incontinent Patients - WFIP

    Bhupathy Alagiriswamy

    Bhupathy AlagiriswamyClinical Trial Manager
    Boehringer Ingelheim

    Sheila Khawaja

    Sheila KhawajaVice-Chair
    World Alliance of Pituitary Organizations (WAPO)

  • 18:00
  • Chairperson’s closing remarks


    Nancy Meyerson-Hess

    Nancy Meyerson-HessChief Compliance and Regulatory Officer
    eMQT

What do the Pass Include


  •  C-Suite keynote sessions & Panel Discussions
  •  Full 2-day live event Access
  •  Interactive live Video chat
  •  Interactive Social lounge with individual tables for discussions & Exchange of Information
  •  Q&A Session and polling
  •  Messaging meetings and networking with Industry Experts and Peers
  •  Access to Virtual expo (including videos, reports and articles from solution providers),
  •  Receiving Handouts
  •  On demand event recordings until 1 month
  •  Certificate for attending

BRING YOUR TEAM
Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to [email protected]for more details.

register now

PARTNERS

Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to [email protected]

Online

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now